Health Center Program, 48426 [2016-17497]
Download as PDF
<![CDATA[
48426
Federal Register / Vol. 81, No. 142 / Monday, July 25, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Health Center Program
Health Resources and Services
Administration, HHS.
ACTION: Notice of class deviations from
the requirements for competition and
application period for the health center
program.
AGENCY:
The Bureau of Primary Health
Care (BPHC) is awarding funds to health
centers transitioning to value-based
models of care, improving the use of
information in decision making, and
increasing engagement in delivery
system transformation.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award:
Approximately 1,380 Health Center
Program award recipients.
Amount of Competitive Awards:
Approximately $90 million will be
awarded in FY 2016 through a one-time
supplement.
Period of Supplemental Funding:
Anticipated 12 month project period is
September 1, 2016 through August 31,
2017.
CFDA Number: 93.224.
SUMMARY:
data to achieve the quality, cost, and
patient-centered goals of delivery
system reforms. In addition, health
centers that do not currently have a
certified electronic health record (EHR)
at all sites and in use by all providers
must propose at a minimum to use
DSHII funding to initiate and/or
increase the number of sites and
providers using a certified EHR. The
investments will help health centers
improve the quality and safety of
services provided to the nation’s most
vulnerable populations.
FOR FURTHER INFORMATION CONTACT:
Olivia Shockey, Expansion Division
Director, Office of Policy and Program
Development, Bureau of Primary Health
Care, Health Resources and Services
Administration at 301–443–9282 or
oshockey@hrsa.gov.
Dated: July 18, 2016.
James Macrae,
Acting Administrator.
[FR Doc. 2016–17497 Filed 7–22–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
mstockstill on DSK3G9T082PROD with NOTICES
Authority: Section 330 of the Public
Health Service Act, as amended (42 U.S.C.
254b, as amended).
AGENCY:
Justification: Targeting the Nation’s
neediest populations and geographic
areas, the Health Center Program
supports more than 1,300 health centers
that operate over 9,000 service delivery
sites in every state, the District of
Columbia, Puerto Rico, the Virgin
Islands, and the Pacific Basin. Nearly 23
million patients received
comprehensive, culturally competent,
quality primary health care services
through the Health Center Program
award recipients in 2014.
The fiscal year (FY) 2016 Health
Center Program Delivery System Health
Information Investment (DSHII) funding
will provide formula-based, one-time
support for the purchase of health
information technology (health IT)
enhancements to accelerate health
centers’ transition to value-based
models of care, improve efforts to share
and use information to support better
decisions, and increase engagement in
delivery system transformation efforts.
Grant funds will help health centers
make strategic investments to enhance
their health IT, implement new clinical
and administrative workflows, develop
new reports, and better prepare
providers and staff to use health IT and
SUMMARY:
VerDate Sep<11>2014
18:27 Jul 22, 2016
Jkt 238001
ACTION:
Office of the Secretary, HHS.
Notice.
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Zhiyu Li, Ph.D., Mount Sinai School
of Medicine: Based upon the evidence
and findings of an investigation report
by the Mount Sinai School of Medicine
(MSSM) and additional analysis
conducted by ORI in its oversight
review, ORI found that Dr. Zhiyu Li,
former Postdoctoral Fellow, MSSM,
engaged in research misconduct in
research that was supported by National
Cancer Institute (NCI), National
Institutes of Health (NIH), grant R21
CA120017. ORI found that falsified and/
or fabricated data were included in the
following published papers, submitted
manuscript, poster presentation, and
grant applications:
• Li, Z., Fallon, J., Mandeli, J., Wetmur,
J., & Woo, S.L.C. ‘‘A Genetically
Enhanced Anaerobic Bacterium for
Oncopathic Therapy of Pancreatic
Cancer.’’ JNCI 100(19):1389–1400,
October 2008 (hereafter referred to as
‘‘JNCI 2008’’) (Retracted 02/2010).
• Li, Z., Fallon, J., Mandeli, J., Wetmur,
J., & Woo, S.L.C. ‘‘The Oncopathic
Potency of Clostridium perfringens is
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Independent of its a-Toxin Gene.’’
HGT 20:751–758, July 2009 (hereafter
referred to as ‘‘HGT 2009’’) (Retracted
03/2010).
• Li, Z., Fallon, J., Mandeli, J., Wetmur,
J., & Woo, S.L.C. ‘‘Oncopathic
Bacteriotherapy with Engineered C.
perfringens Spores is Superior and
Complementary to Gemcitabine
Treatment in an Orthotopic Murine
Model of Pancreatic Cancer.’’
Submitted for publication in Can. Res.
(hereafter referred to as the ‘‘Can. Res.
Manuscript 2009’’).
• Li, Z., Fallon, J., Mandeli, J., Wetmur,
J., & Woo, S.L.C. ‘‘Oncopathic
Bacteriotherapy with Cp/plc-/sod-/
PVL is Complementary to
Gemcitabine Treatment for Pancreatic
Cancer in Mice.’’ Presented at the
12th Annual Meeting of the American
Society of Gene Therapy, May 27–30,
2009.
• R21 CA120017–02
• R21 CA120017 Final Progress Report
• R01 CA130897–01
• R01 CA130897–01 A1
• R01 CA130897–01 A2
• R01 CA130897–01 A2 Supplemental
Material
• R01 CA148697–01
The JNCI 2008 and HGT 2009 papers
were retracted, and the Can. Res.
Manuscript 2009 was withdrawn.
ORI found that the Respondent
intentionally, knowingly, and recklessly
engaged in research misconduct by
falsely claiming to have generated
recombinant Clostridium perfringens
(Cp) strains, Cp/sod-, Cp/sod-/PVL, and
Cp/plc-/sod-/PVL, to depict the effects
of recombinant Cp strains on their
ability to destroy cancer cells in a
murine model, when these bacterial
strains were not produced nor the data
derived from them, and by falsifying
histopathological data reported in fiftyseven (57) images in two (2) published
papers, one (1) submitted manuscript,
two (2) poster presentations, and seven
(7) of Respondent’s supervisor’s grant
applications and fabricating the
corresponding nineteen (19) summary
bar graphs that were based on those
false images.
Specifically, Respondent trimmed and
used portions of Figure 6 (right panel)
of a draft R21 CA120017–01 grant
application, representing an image of
liver tumor two (2) days after injection
of Cp/plc- bacteria, to represent
unrelated results from different
experiments in:
• Figures 5D and 7C (left panel), grant
R21 CA120017 Final Progress Report
• Figure 6A, grant R01 CA130897–01
• Figures 9D and 17A (top left, middle,
and right panels and bottom left
panel), grant R01 CA130897–01 A1
E:\FR\FM\25JYN1.SGM
25JYN1
]]>Agencies
[Federal Register Volume 81, Number 142 (Monday, July 25, 2016)]
[Notices]
[Page 48426]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17497]
[[Page 48426]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Health Center Program
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice of class deviations from the requirements for
competition and application period for the health center program.
-----------------------------------------------------------------------
SUMMARY: The Bureau of Primary Health Care (BPHC) is awarding funds to
health centers transitioning to value-based models of care, improving
the use of information in decision making, and increasing engagement in
delivery system transformation.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: Approximately 1,380 Health Center
Program award recipients.
Amount of Competitive Awards: Approximately $90 million will be
awarded in FY 2016 through a one-time supplement.
Period of Supplemental Funding: Anticipated 12 month project period
is September 1, 2016 through August 31, 2017.
CFDA Number: 93.224.
Authority: Section 330 of the Public Health Service Act, as
amended (42 U.S.C. 254b, as amended).
Justification: Targeting the Nation's neediest populations and
geographic areas, the Health Center Program supports more than 1,300
health centers that operate over 9,000 service delivery sites in every
state, the District of Columbia, Puerto Rico, the Virgin Islands, and
the Pacific Basin. Nearly 23 million patients received comprehensive,
culturally competent, quality primary health care services through the
Health Center Program award recipients in 2014.
The fiscal year (FY) 2016 Health Center Program Delivery System
Health Information Investment (DSHII) funding will provide formula-
based, one-time support for the purchase of health information
technology (health IT) enhancements to accelerate health centers'
transition to value-based models of care, improve efforts to share and
use information to support better decisions, and increase engagement in
delivery system transformation efforts. Grant funds will help health
centers make strategic investments to enhance their health IT,
implement new clinical and administrative workflows, develop new
reports, and better prepare providers and staff to use health IT and
data to achieve the quality, cost, and patient-centered goals of
delivery system reforms. In addition, health centers that do not
currently have a certified electronic health record (EHR) at all sites
and in use by all providers must propose at a minimum to use DSHII
funding to initiate and/or increase the number of sites and providers
using a certified EHR. The investments will help health centers improve
the quality and safety of services provided to the nation's most
vulnerable populations.
FOR FURTHER INFORMATION CONTACT: Olivia Shockey, Expansion Division
Director, Office of Policy and Program Development, Bureau of Primary
Health Care, Health Resources and Services Administration at 301-443-
9282 or oshockey@hrsa.gov.
Dated: July 18, 2016.
James Macrae,
Acting Administrator.
[FR Doc. 2016-17497 Filed 7-22-16; 8:45 am]
BILLING CODE 4165-15-P
